Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels

Cancer Research

Volumn 56, Issue 23, 1996, Pages 5391-5396

  Larcher, Fernando ^a   Robles, Ana I ^c   Duran, Hebe ^c   Murillas, Rodolfo ^a   Quintanilla, Miguel ^b   Cano, Amparo ^b   Conti, Claudio J ^c   Jorcano, José Luis ^a  

^a CIEMAT   (Spain)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL IMMORTALIZATION; FEMALE; GENE EXPRESSION; KERATINOCYTE; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; KERATINOCYTES; LYMPHOKINES; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED SENCAR; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; ONCOGENE PROTEIN P21(RAS); PAPILLOMA; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS P21(RAS); RNA, MESSENGER; RNA, NEOPLASM; SIALOGLYCOPROTEINS; SKIN NEOPLASMS; SPECIES SPECIFICITY; TETRADECANOYLPHORBOL ACETATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030447757     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Folkman, J Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med , 1: 27-31, 1995
2. Fidler, I , and Ellis, L. The implications of angiogenesis for the biology and therapy of cancer metastasis Cell, 79: 185-188, 1994
3. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V S., and Dvorak, H F Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Washington DC), 219: 983-985, 1983.
4. Senger, D. R , Brown, L. F., Claffey, K P , and Dvorak, H. F. Vascular permeability factor, tumor angiogenesis and stroma generation Invasion Metastasis, 14: 385-394, 1994
5. Leung, D W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen Science (Washington DC)., 246: 1306-1309, 1989.
6. Keck, P. J., Hauser, S. D., Krivi, G , Sanzo, K , Warren, T., Feder, J., and Connolly, D. T. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science (Washington DC), 246: 1309-1312, 1989.
7. Shweiki, D , Itin, A., Doffer, D , and Keshet, E Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
8. Shweiki D , Neeman M., Itin A., and Keshet, E. Induction of vascular endothelial growth factor expression by hypoxia and glucose deficiency in multicell spheroids: Implications in tumor angiogenesis. Proc Natl Acad. Sci USA, 92: 768-772, 1995.
9. Berse, B., Brown, L. F. Van de Water, L , Dvorak, H. F., and Senger, D. R Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell, 3: 211-220, 1992.
10. Plate, K H., Breier, G., Weich, H A , and Risau, W Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359. 845-848, 1992.
11. Millauer, B., Shawver, L , Plate, K. H , Risau, W., and Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (Lond.), 367: 576-579, 1994
12. Quintanilla, M., Brown, K., Ramsden, M , and Balmain, A Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature (Lond), 322: 78-80, 1986.
13. Brown, K , Buchmann, A., and Balmain, A Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression Proc Natl. Acad. Sci USA, 87 538-542, 1990.
14. Bremner, R , and Balmain, A. Genetic changes in skin tumor progression, correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell 61: 407-417, 1990.
15. Bianchi, A , Aldaz, C. M., and Conti, C. J. Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors Proc. Natl. Acad. Sci. USA, 87 6902-6906, 1990
16. Buchmann, A., Ruggeri, B , Klein-Szanto, A. J P., and Balmain, A Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7 Cancer Res , 51: 4097-4101, 1991.
17. Rak, J., Mitsuhashi, Y , Bayko, L , Filmus, J , Shrisawa T , and Kerbel, R. S. Mutant ras oncogenes up-regulate VEGF/VPF expression implications for induction and inhibition of tumor angiogenesis Cancer Res , 55. 4575-4580, 1995.
18. Grugel, S., Finkenzeller, G , Weindel, K., Barleon B., and Marme, D. Both v-H-ras and v-raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells J Biol. Chem , 270 25915-25919, 1995
19. Detmar, M , Yeo, K-T , Nagy, J A , Van de Water, L , Brown, L F., Berse, B., Elicker, B. M , Ledbetter, S , and Dvorak, H. F Keratinocyte-derived vascular permeability factor(vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest. Dermatol., 105: 44-50, 1995.
20. Frank, S , Hubner, G., Breier, G., Longaker, M T , Greenhalgh D G , and Werner, S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes Implications for normal and impaired wound healing. J. Biol. Chem., 270: 12607-12613, 1995
21. Ballaun, C., Weninger, W , Uthman, A., Weich, H , and Tschachler, E. Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J. Invest. Dermatol., 104: 7-10, 1995
22. Brown, L. F., Yeo, K-T., Berse, B , Senger, D. R., Dvorak, H. F., and Van de Water, L Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing J. Exp. Med , 176: 1375-1379, 1992.
23. Detmar, M., Brown, L. F., Claffey, K. P., Yeo, T-K , Kocher, O., Jackman, R. W., Berse, B , and Dvorak, H. F. Overexpression of vascular permeability factor and its receptors in psoriasis J. Exp. Med., 180: 1141-1146, 1994.
24. Brown, L. F., Harrist, T. J., Yeo, K-T., Stale-Bäckdahl, M , Jackman, R. W., Berse, B., Tognazzi, K., Dvorak, H. F , and Detmar, M. Increased expression of vascular permeability factor (VEGF) in bullous pemphigoid, dermatitis herpetiformis and erythema multiforme. J Invest. Dermatol., 104. 744-749, 1995.
25. Quintanilla, M., Haddow, S , Jonas, D., Jaffe, D., Bowden, G. T., and Balmain, A Comparison of ras activation during epidermal carcinogenesis in vitro and in vivo. Carcinogenesis (Lond), 12: 1875-1881, 1991.
26. Diaz-Guerra, M., Haddow, S., Bauluz, C., Jorcano, J L., Cano, A., Balmain, A., and Quintanilla, M. Expression of simple epithelial cytokeratins in mouse epidermal keratinocytes harboring Harvey ras gene alterations Cancer Res., 52: 680-687, 1992.
27. Yuspa, S. H., Morgan, D , Lichti, U., Spangler, E. F , Michael, D., Kilkenny, A., and Hennings, H. Cultivation and characterization of cells derived from mouse skin papillomas induced by an initiation-promotion protocol. Carcinogenesis (Lond.), 7: 949-958, 1986.
28. Navarro, P., Gómez, M., Pizarro, A , Gamallo, C., and Cano, A. A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis. J. Cell Biol., 115: 517-533, 1991.
29. Caulín, C., Lopez-Barcons, L., González-Garrigues, M., Navarro, P., Lozano, E., Rodrigo, I., Gamallo, C., Cano, A., Fabra, A , and Quintanilla, M. Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced levels of Ha-ras oncogene products. Mol. Carcinog., 15: 104-114, 1996
30. Roop, D. R , Lowy, D. R., Tambourin, P. E., and Yuspa, S. H. An activated Harvey-ras oncogene produces benign tumors on mouse epidermal tissue. Nature (Lond.), 323. 822-824, 1986
31. Chomczynski, P., and Sacchi, N Single-step method of RNA isolation by acid-guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem., 162. 156-159, 1987.
32. Casanova, L , Bravo, A., Were, F., Ramirez, A , Jorcano, J. L , and Vidal, M. Tissue-specific and efficient expression of the human simple epithelial keratin 8 gene in transgenic mice. J. Cell Sci., 108: 811-820, 1995
33. Ellis, R. W., DeFeo, D., Maryak, J M., Young, H A., Shih, T. Y., Chang, E. H , and Scholnick, E. M. Dual evolutionary origin for the rat genomic sequences of Harvey murine sarcoma virus. J. Virol., 36. 408-420, 1980.
34. Ushmorov, A. G., Fürsternberger, G., Faissner, A., and Marks, F. Effects of complete and incomplete tumor promoters in hair growth, angiogenesis and tenascin in the skin of NMRI mice. Carcinogenesis (Lond.), 15: 2739-2745, 1994.
35. Breier, G., Albrecht, U., Sterrer, S , and Risau, W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation Development (Camb.), 114: 521-532, 1992.
36. Olofsson, B., Pajusola, K., Kaipainen, A., von Euler, G., Joukov, V., Saksela, O., Orpana, A , Paterson, R. F , Alitalo, K., and Eriksson, U Vascular endothelial growth factor B A novel growth factor for endothelial cells. Proc. Natl Acad. Sci. USA., 93 2576-2581, 1996
37. DiGiovanni, J , Walker, S. E , Beltrán, L M , Naito, M , and Eastin, W. C. Evidence for a common genetic pathway controlling susceptibility to mouse skin tumor promotion by diverse classes of promoting agents. Cancer Res., 51. 1398-1405, 1991
38. Lee, W. Y., Fischer, S. M., Butler, A. P., and Locniskar, M. F Modulation of interleukin-1α mRNA expression in mouse epidermis by tumor promoter and antagonists. Mol. Carcinog., 7. 26-35, 1993.
39. Cooper, K. D., Hammerberg, C., and Baasgaard, O Interleukin-1 in human skin: dysregulation in psoriasis. J. Invest. Dermatol., 95. 24S-26S, 1990.
40. Larcher, F., Bauluz, C., Diaz-Guerra, M., Ballestin C., Conti, C. J., and Jorcano, J. L. Aberrant expression of the simple epithelia type II keratin 8 in carcinomas but not papillomas. Mol. Carcinog., 6. 112-121, 1992
41. Brown, K., Quintanilla, M., Ramsden, M , Kerr, I. B., Young, S., and Balmain, A. v-ras genes from Harvey and Balb murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis. Cell, 46: 447-456, 1986
42. Ruggeri, B., Caamano, J., Goodrow, T., DiRado, M., Bianchi, A., Trono, D., Conti, C. J., and Klein-Szanto, A J. P Alterations of p53 tumor suppressor gene during mouse skin tumor progression. Cancer Res., 51: 6615-6621, 1991.
43. Kemp, C. J., Donehower, L. A , Bradley, A., and Balmain, A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell, 74: 813-822, 1993
44. Kieser, A., Weich, H. A., Brandner, G., Marmé, D., and Kolch, W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene, 9: 963-969, 1994.
45. Carmellet, P. Ferreira, V., Breier, G , Pollefeyt, S , Kiecksens, L , Gersenstein, M , Fahrig, M , Vandenhoeck, A , Harpal, K., Eberhardt, C., Declercq, C , Pawling, J , Moons, L , Collen, D., Risau, W., and Nagy, A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature (Lond), 380. 435-439, 1996.
46. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M , Lu, L , O'Shea, K. S., Powell-Braxton, L., Hillan, K. J , and Moore, M. W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (Lond), 380: 389-442, 1996.
47. Imamoto, A., Beltrán, L., Fujiki, H., Chenicek, K J , and DiGiovanni, J. Enhanced induction of epidermal ornithine decarboxylase activity in C57B1/6 compared to DBA/2 mice by protein kinase C-activating skin tumor promoters: relevance to genetically mediated differences in promotion susceptibility Carcinogenesis (Lond), 13: 177-182, 1992
48. Kennard, M. D., Kang, D-C., Montgomery, R L., and Butler, A. P Expression of epidermal ornithine decarboxylase and nuclear proto-oncogenes in phorbol ester tumor promotion-sensitive and-resistant mice. Mol. Carcinog., 12: 14-22, 1995.
49. Hu, D. E , and Fan, T P. Protein kinase C inhibitor calphostin C prevents cytokine-induced angiogenesis in the rat. Inflammation, 19: 39-54, 1995.
50. Gimenez-Conti, I. B , Bianchi, A B., Fischer, S. M , Rainers, J. J., Jr., Conti, C. J., and Slaga, T. J Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice. Cancer Res., 52: 3432-3435, 1992.
51. Nagase, H., Bryson, S., Cordell, H , Kemp, C. J., Fee, F., and Balmain, A. Distinct genetic loci control development of benign and malignant skin tumors in mice Nat. Genet., 10: 424-429, 1995
52. Saez, E., Rutberg, S. H., Mueller, E., Oppenheim, H., Smoluk, J , Yuspa, S. H., and Spiegelman, B. M. c-fos is required for malignant progression of skin tumors Cell, 82: 721-732, 1995.
53. Zenklusen, J. C., Fischer, S. M. and Conti, C. J. Angiogenesis is an early step in two-stage mouse carcinogenesis. Proc. Am. Assoc. Cancer Res., 35: 129, 1994.
54. Viglietto, G., Maglione, D., Rambaldi, M , Cerutti, J., Romano, A , Trapasso, F , Fedele, M., Ippolito, P., Chiappetta, G., Botti, G , Fusco, A., and Persico, M. G Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PIGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene, 11: 1569-1579, 1995.
55. Aldaz, C M , Trono, D , Larcher, F , Slaga, T. J., and Conti, C J Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions. Mol. Carcinog , 2: 22-26, 1989